Related Experiment Video
Updated: Jan 27, 2026
10:43
High-throughput Identification of Bacteria Repellent Polymers for Medical Devices
Published on: November 5, 2016
9.5K
Confronting the medical devices jungle.
1Independent Journalist and Researcher, Seadoll, 54 Chimbai Rd, Bandra (W), Mumbai 400 050 India., sandhya199@gmail.com.
Indian Journal of Medical Ethics
|March 29, 2019
Summary
International medical device manufacturers are implicated in health scandals in India, selling untested products. A flawed regulatory system prioritizes industry growth over patient safety, contributing to negligence.
Area of Science:
- Public Health
- Medical Device Regulation
- Health Economics
Background:
- Recent reports highlight a pattern of health scandals in India.
- The International Consortium of Investigative Journalists (ICIJ) has investigated the international medical device industry.
Discussion:
- Manufacturers are accused of selling untested medical devices at excessive prices.
- Medical professionals and institutions face allegations of criminal negligence.
- The regulatory framework appears to favor industry expansion over patient well-being.
Key Insights:
- A convergence of factors contributes to patient harm.
- Lack of rigorous testing and oversight exacerbates risks.
- Profit motives may override safety considerations in the medical device sector.
Outlook:
- Urgent need for regulatory reform to prioritize patient safety.
- Increased transparency and accountability within the medical device industry are crucial.
- Further investigation into specific cases of negligence and device failure is warranted.
Related Concept Videos
01:23Inhaled Medications
775
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
775
01:18Endocarditis III: Medical Management
237
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
237
01:14Myocarditis III: Medical Management
202
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
202
01:17Pericarditis III: Medical Management
344
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
344
01:30Heart Failure V: Medical Management
258
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
258
01:26Nephrotic Syndrome II : Assessment and Medical Management
235
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
235